Xavier Hernandez Yague

Patient and tumor characteristics as determinants of overall survival (OS) in BRAF V600 mutant (mt) metastatic colorectal cancer (mCRC) treated with doublet or triplet targeted therapy.

J. Tabernero, R. Dienstmann, I. Chicote, 2020 .